BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 63.34%
This Quarter Est. Return
1 Year Est. Return
+63.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.1B
AUM Growth
+$59.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
101
New
Increased
Reduced
Closed

Top Buys

1 +$81.5M
2 +$56.4M
3 +$27.2M
4
DYAX
DYAX CORPORATION
DYAX
+$15.3M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$13.8M

Top Sells

1 +$220M
2 +$51.8M
3 +$30.8M
4
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$24.5M
5
AEGR
Aegerion Pharmaceuticals
AEGR
+$22.7M

Sector Composition

1 Healthcare 44.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$922M 13%
8,719,218
-290,993
2
$827M 11.66%
20,735,926
+1,412,979
3
$750M 10.57%
14,810,559
4
$665M 9.37%
10,273,182
5
$499M 7.03%
19,955,126
6
$400M 5.63%
13,650,835
7
$155M 2.18%
1,151,619
8
$137M 1.92%
1,941,304
+1,157,993
9
$94.4M 1.33%
6,297,026
-720,582
10
$59.5M 0.84%
4,791,179
11
$54.5M 0.77%
8,455,306
12
$50.9M 0.72%
6,699,979
13
$50.8M 0.72%
2,778,654
14
$42.2M 0.6%
775,864
+230,018
15
$42M 0.59%
2,500,000
+1,623,537
16
$41.8M 0.59%
556,108
-689,692
17
$39.6M 0.56%
2,380,074
+400,000
18
$35.5M 0.5%
500,000
-320,275
19
$33.5M 0.47%
3,090,000
-50,000
20
$32M 0.45%
530,738
+228,994
21
$27.7M 0.39%
2,558,857
22
$25.7M 0.36%
5,794,753
23
$25.4M 0.36%
796,662
24
$24.8M 0.35%
362,847
25
$22.4M 0.32%
4,200,000